InsiderClue
Insiders · Profile

SATO VICKI L

Director at Vir Biotechnology · Director at Denali Therapeutics · Director at Revvity. Filing since 10 Feb 2009. CIK 0001197020

VIR Vir Biotechnology, Inc. Director · 36 trades DNLI Denali Therapeutics Inc. Director · 28 trades RVTY Revvity Director · 9 trades
Company
Date
Role
Action
Shares
Amount
Of holding
VIR Vir Biotechnology, Inc.
1 May 2026
Director
Sold on a plan
22,000
$221.03K
2.0%
VIR Vir Biotechnology, Inc.
1 Apr 2026
Director
Sold on a plan
22,000
$199.62K
2.0%
VIR Vir Biotechnology, Inc.
2 Mar 2026
Director
Sold on a plan
22,000
$209.18K
1.9%
VIR Vir Biotechnology, Inc.
24 Feb 2026
Director
Sold on a plan
42,377
$413.37K
3.6%
VIR Vir Biotechnology, Inc.
2 Feb 2026
Director
Sold on a plan
22,000
$169.67K
1.9%
VIR Vir Biotechnology, Inc.
2 Jan 2026
Director
Sold on a plan
22,000
$130.38K
1.9%
VIR Vir Biotechnology, Inc.
1 Dec 2025
Director
Sold on a plan
22,000
$132.07K
1.8%
VIR Vir Biotechnology, Inc.
3 Nov 2025
Director
Sold on a plan
22,000
$124.05K
1.8%
VIR Vir Biotechnology, Inc.
1 Oct 2025
Director
Sold on a plan
22,000
$128.40K
1.8%
VIR Vir Biotechnology, Inc.
2 Sep 2025
Director
Sold on a plan
22,000
$109.81K
1.7%
VIR Vir Biotechnology, Inc.
1 Aug 2025
Director
Sold on a plan
22,000
$109.70K
1.7%
VIR Vir Biotechnology, Inc.
1 Jul 2025
Director
Sold on a plan
22,000
$112.21K
1.7%
VIR Vir Biotechnology, Inc.
8 Jan 2025
Director
Sold on a plan
10,960
$137.22K
0.8%
DNLI Denali Therapeutics Inc.
2 Jan 2025
Director
Sold on a plan
3,080
$64.40K
2.8%
DNLI Denali Therapeutics Inc.
7 Nov 2024
Director
Sold on a plan
1,020
$30.60K
0.9%
DNLI Denali Therapeutics Inc.
1 Nov 2024
Director
Sold on a plan
3,080
$83.38K
2.7%
DNLI Denali Therapeutics Inc.
13 Sep 2024
Director
Sold on a plan
1,020
$30.60K
0.9%
DNLI Denali Therapeutics Inc.
3 Sep 2024
Director
Sold on a plan
3,080
$77.01K
2.6%
DNLI Denali Therapeutics Inc.
1 Jul 2024
Director
Sold on a plan
3,080
$68.20K
2.5%
DNLI Denali Therapeutics Inc.
15 May 2024
Director
Sold on a plan
1,674
$34.13K
1.4%
DNLI Denali Therapeutics Inc.
15 Apr 2024
Director
Sold on a plan
1,666
$30.47K
1.4%
DNLI Denali Therapeutics Inc.
15 Mar 2024
Director
Sold on a plan
1,666
$33.49K
1.4%
DNLI Denali Therapeutics Inc.
15 Feb 2024
Director
Sold on a plan
1,666
$30.60K
1.4%
DNLI Denali Therapeutics Inc.
16 Jan 2024
Director
Sold on a plan
1,666
$30.69K
1.3%
DNLI Denali Therapeutics Inc.
15 Dec 2023
Director
Sold on a plan
1,666
$38.97K
1.3%
DNLI Denali Therapeutics Inc.
15 Nov 2023
Director
Sold on a plan
1,666
$31.87K
1.3%
DNLI Denali Therapeutics Inc.
16 Oct 2023
Director
Sold on a plan
1,666
$34.42K
1.3%
DNLI Denali Therapeutics Inc.
15 Sep 2023
Director
Sold on a plan
1,666
$39.35K
1.3%
DNLI Denali Therapeutics Inc.
15 Aug 2023
Director
Sold on a plan
1,666
$40.48K
1.3%
DNLI Denali Therapeutics Inc.
17 Jul 2023
Director
Sold on a plan
1,666
$49.31K
1.2%
VIR Vir Biotechnology, Inc.
30 Jun 2023
Director
Sold on a plan
18,000
$443.92K
1.4%
DNLI Denali Therapeutics Inc.
28 Jun 2023
Director
Sold on a plan
1,666
$49.71K
1.2%
VIR Vir Biotechnology, Inc.
8 Mar 2023
Director
Sold, plan not stated
17,935
$405.06K
1.3%
VIR Vir Biotechnology, Inc.
8 Feb 2023
Director
Sold, plan not stated
17,915
$508.34K
1.3%
VIR Vir Biotechnology, Inc.
9 Jan 2023
Director
Sold, plan not stated
17,915
$462.78K
1.3%
VIR Vir Biotechnology, Inc.
8 Dec 2022
Director
Sold, plan not stated
17,915
$462.37K
1.3%
VIR Vir Biotechnology, Inc.
8 Nov 2022
Director
Sold, plan not stated
17,915
$490.55K
1.3%
VIR Vir Biotechnology, Inc.
10 Oct 2022
Director
Sold, plan not stated
17,915
$370.28K
1.2%
VIR Vir Biotechnology, Inc.
8 Sep 2022
Director
Sold, plan not stated
17,915
$392.33K
1.2%
VIR Vir Biotechnology, Inc.
8 Aug 2022
Director
Sold, plan not stated
17,915
$542.68K
1.2%
VIR Vir Biotechnology, Inc.
8 Jul 2022
Director
Sold, plan not stated
17,915
$520.69K
1.2%
VIR Vir Biotechnology, Inc.
8 Jun 2022
Director
Sold, plan not stated
17,915
$462.98K
1.2%
VIR Vir Biotechnology, Inc.
24 May 2022
Director
Sold, plan not stated
3,374
$80.37K
0.2%
VIR Vir Biotechnology, Inc.
9 May 2022
Director
Sold, plan not stated
14,541
$299.84K
1.0%
VIR Vir Biotechnology, Inc.
28 Apr 2022
Director
Sold, plan not stated
17,915
$374.42K
1.2%
VIR Vir Biotechnology, Inc.
18 Jan 2022
Director
Sold, plan not stated
15,173
$567.39K
1.0%
VIR Vir Biotechnology, Inc.
20 Dec 2021
Director
Sold, plan not stated
15,174
$827.48K
1.0%
VIR Vir Biotechnology, Inc.
26 Nov 2021
Director
Sold, plan not stated
15,174
$558.40K
1.0%
DNLI Denali Therapeutics Inc.
10 Nov 2021
Director
Sold, plan not stated
1,666
$87.98K
1.3%
DNLI Denali Therapeutics Inc.
1 Nov 2021
Director
Sold, plan not stated
1,666
$83.38K
1.3%
VIR Vir Biotechnology, Inc.
19 Oct 2021
Director
Sold, plan not stated
15,174
$600.31K
1.0%
VIR Vir Biotechnology, Inc.
17 Sep 2021
Director
Sold, plan not stated
15,174
$796.30K
0.9%
DNLI Denali Therapeutics Inc.
15 Sep 2021
Director
Sold, plan not stated
1,666
$88.97K
1.3%
VIR Vir Biotechnology, Inc.
19 Aug 2021
Director
Sold, plan not stated
15,174
$683.61K
0.9%
DNLI Denali Therapeutics Inc.
18 Aug 2021
Director
Sold, plan not stated
1,666
$86.14K
1.3%
DNLI Denali Therapeutics Inc.
21 Jul 2021
Director
Sold, plan not stated
1,666
$108.51K
1.2%
VIR Vir Biotechnology, Inc.
19 Jul 2021
Director
Sold, plan not stated
15,174
$564.51K
0.9%
DNLI Denali Therapeutics Inc.
23 Jun 2021
Director
Sold, plan not stated
1,666
$117.84K
1.2%
VIR Vir Biotechnology, Inc.
21 Jun 2021
Director
Sold, plan not stated
15,174
$700.52K
0.9%
DNLI Denali Therapeutics Inc.
26 May 2021
Director
Sold, plan not stated
1,666
$108.91K
1.2%
VIR Vir Biotechnology, Inc.
19 May 2021
Director
Sold, plan not stated
15,174
$664.60K
0.9%
DNLI Denali Therapeutics Inc.
28 Apr 2021
Director
Sold, plan not stated
1,666
$103.54K
1.2%
DNLI Denali Therapeutics Inc.
31 Mar 2021
Director
Sold, plan not stated
1,666
$93.99K
1.2%
DNLI Denali Therapeutics Inc.
3 Mar 2021
Director
Sold, plan not stated
1,666
$102.64K
1.2%
RVTY Revvity
9 Feb 2017
Director
Sold, plan not stated
8,308
$448.72K
21.7%
RVTY Revvity
10 May 2016
Director
Sold, plan not stated
12,586
$686.01K
32.0%
RVTY Revvity
10 Feb 2015
Director
Sold, plan not stated
16,800
$765.36K
41.4%
RVTY Revvity
9 Feb 2015
Director
Sold, plan not stated
7,200
$327.80K
15.1%
RVTY Revvity
14 Feb 2014
Director
Sold, plan not stated
21,843
$960.35K
32.5%
RVTY Revvity
30 Apr 2013
Director
Sold, plan not stated
6,440
$196.61K
13.3%
RVTY Revvity
8 Feb 2012
Director
Sold, plan not stated
5,865
$153.25K
13.2%
RVTY Revvity
5 Nov 2009
Director
Sold, plan not stated
7,893
$149.04K
20.5%
RVTY Revvity
10 Feb 2009
Director
Sold, plan not stated
6,300
$90.36K
20.2%
73 decisions on file.